Cytodyn Inc (CYDY)

[justdafactss]

CytoDyn CEO sold a massive stake on April 30

Insider transactions are closely monitored by investors to gauge a measure of company prospects, rightly so, because these insiders have an information advantage over outsiders to know where a company is headed. Relying solely on insider buys and sells is, by no means, a viable strategy to generate attractive investment returns. However, ignoring them altogether could lead to unwelcome returns as well.

Nader Pourhassan, the CytoDyn CEO, has sold 4.8 million-plus shares on April 30 for $15.67 million.

This was filed in a Form 144 and an investor might find it difficult to locate this document in the Edgar system. Please visit this section of the SEC website to find the document.

It seems as if everything is going right for the company. Therefore, a sale of this nature might be an indication of troubles ahead for the company. Troubles that retail investors and analysts are yet to discover. There’s reason to believe that CYDY is one of the few small biotech companies that are making some actual progress in finding a treatment for Covid-19, as opposed to some other companies that are pumping the share price artificially. However, this recent transaction by the CEO should act as a warning sign for investors who are waiting on the sidelines to pounce on CYDY when the market opens for trading on Monday, the May third.

https://beatbillions.com/a-piece-of-cydy-news-you-probably-didnt-notice/